Serina Therapeutics, Inc. (SER) bonds
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.39−0.02 (-1.42%)
Close on Nov 13, 2026Market cap $35.31MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Serina Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Serina Therapeutics's 10-Q for the period ended Sep 30, 2025
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| 2025 Convertible Note Convertible at $5 a share | 10.00% | $20.00M | $2.90M |
| 2025 Convertible Note, Tranche Five Convertible | – | $5.00M | – |
| 2025 Convertible Note, Tranche Four Convertible | – | $5.00M | – |
| 2025 Convertible Note, Tranche One Convertible | – | $5.00M | – |
| 2025 Convertible Note, Tranche Three Convertible | – | $2.50M | – |
| 2025 Convertible Note, Tranche Two Convertible | – | $2.50M | – |
| Convertible Promissory Note Convertible | – | $10.00M | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?